SeroFlash SARS-CoV-2 IgM/IgG Antibody Detection Kit |
|||
D-1001-025 | EpiGentek | 25 tests | EUR 399.3 |
Human IgG antibody Laboratories manufactures the new york sars-cov microsphere immunoassay for antibody detection reagents distributed by Genprice. The New York Sars-Cov Microsphere Immunoassay For Antibody Detection reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other New products are available in stock. Specificity: New Category: York Group: Sars-Cov Microsphere
SARS-CoV Matrix Antibody |
||
ProSci | 0.02 mg | EUR 206.18 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4). |
SARS-CoV Matrix Antibody |
||
ProSci | 0.1 mg | EUR 523.7 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4). |
SARS-CoV Envelope Antibody |
||
ProSci | 0.02 mg | EUR 206.18 |
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication. |
SARS-CoV Envelope Antibody |
||
ProSci | 0.1 mg | EUR 523.7 |
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication. |
SARS-CoV Spike Antibody |
||
ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
||
ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
||
ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
Sars-Cov Microsphere information
Human IgG AssayLite Fluorescent Immunoassay Kit |
|||
FEI7200 | AssayPro | 96 Well Plate | EUR 475.2 |
Human IgM AssayLite Fluorescent Immunoassay Kit |
|||
FEI7301 | AssayPro | 96 Well Plate | EUR 475.2 |
Rat Albumin AssayLite Fluorescent Immunoassay Kit |
|||
FERA2201 | AssayPro | 96 Well Plate | EUR 475.2 |
Mouse Albumin AssayLite Fluorescent Immunoassay Kit |
|||
FEMA2201 | AssayPro | 96 Well Plate | EUR 475.2 |
Human Albumin AssayLite Fluorescent Immunoassay Kit |
|||
FEA2201 | AssayPro | 96 Well Plate | EUR 475.2 |
CaspSELECT? Caspase-3 Immunoassay Kit (Fluorometric) |
|||
K163-100 | Biovision | each | EUR 901.2 |
Human Prealbumin AssayLite Fluorescent Immunoassay Kit |
|||
FEP2010 | AssayPro | 96 Well Plate | EUR 475.2 |
Rapid Gold Immuno-assay Kit for Antibody IgG to Tuberculosis (TB) |
|||
Z7010010 | Biochain | 1 kit | EUR 247 |
QuickTiter Adenovirus Titer Immunoassay Kit, Trial Size |
|||
VPK-109-T | Cell Biolabs | 20 assays | EUR 448.8 |
Description: Accurate measurement of adenovirus titer is critical for gene delivery. Traditional plaque-forming unit (PFU) assays are long and suffer from high inter-assay variability. The QuickTiter Adenovirus Titer Immunoassay Kit provide a quick, complete system to functionally titer virus infectivity. The assay recognizes all 41 serotypes of adenovirus, and can be used with any adenovirus system that can amplify in HEK 293 cells. |
Human Haptoglobin AssayLite Fluorescent Immunoassay Kit |
|||
FEH1003 | AssayPro | 96 Well Plate | EUR 475.2 |
Human Ceruloplasmin AssayLite Fluorescent Immunoassay Kit |
|||
FEC5201 | AssayPro | 96 Well Plate | EUR 475.2 |
Human Complement C3 AssayLite Fluorescent Immunoassay Kit |
|||
FEC2101 | AssayPro | 96 Well Plate | EUR 475.2 |
Human Complement C4 AssayLite Fluorescent Immunoassay Kit |
|||
FEC2102 | AssayPro | 96 Well Plate | EUR 475.2 |
Human Fibrinogen (FBG) AssayLite Fluorescent Immunoassay Kit |
|||
FEF1040 | AssayPro | 96 Well Plate | EUR 475.2 |
Human Estrone-3-Glucuronide (E1G)Enzyme Immunoassay ELISA Kit |
|||
QY-E05423 | Qayee Biotechnology | 96T | EUR 433.2 |
Human Alpha-1-Antitrypsin AssayLite Fluorescent Immunoassay Kit |
|||
FEA5101 | AssayPro | 96 Well Plate | EUR 475.2 |
Human IgA, IgG and IgM AssayLite Multiplex Fluorescent Immunoassay Kit |
|||
FI700161M3 | AssayPro | 96 Well Plate | EUR 1472.4 |